Edwards Lifesciences | EW - Assets

Stock Price
82.61
Daily Change
0.17 0.21%
Monthly
-1.97%
Yearly
15.62%
Q1 Forecast
77.31

Edwards Lifesciences reported $13.27B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Artivion USD 857.66M 19.27M Sep/2025
AtriCure USD 654.18M 18.74M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Boston Scientific USD 43.67B 966M Dec/2025
Cooper Companies USD 12.39B 18.1M Sep/2025
Dexcom USD 6.34B 1.16B Dec/2025
Edwards Lifesciences USD 13.27B 216.5M Sep/2025
Globus Medical USD 5.1B 134.55M Sep/2025
Hologic USD 9.18B 165.8M Dec/2025
ICU Medical USD 4.05B 52.39M Dec/2025
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.19B 161.1M Dec/2025
Integra LifeSciences USD 3.65B 21.45M Sep/2025
Intuitive Surgical USD 20.46B 1.11B Dec/2025
J&J USD 199.21B 6.39B Dec/2025
Masimo USD 1.82B 585.1M Sep/2025
Medtronic USD 91.35B 374M Sep/2025
Merit Medical Systems USD 2.63B 44.95M Sep/2025
Stryker USD 47.84B 787M Dec/2025
Tandem Diabetes Care USD 881.11M 6.46M Dec/2025
Teleflex USD 7.87B 496.72M Sep/2025
Zimmer Biomet Holdings USD 23.09B 396.3M Dec/2025